RhumbLine Advisers’s Fortress Biotech FBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-4,607
| Closed | -$94K | – | 3143 |
|
|
2022
Q1 | $94K | Buy |
4,607
+586
| +15% | +$12K | ﹤0.01% | 2897 |
|
|
2021
Q4 | $151K | Sell |
4,021
-20
| -0.5% | -$751 | ﹤0.01% | 2886 |
|
|
2021
Q3 | $195K | Buy |
4,041
+164
| +4% | +$7.91K | ﹤0.01% | 2917 |
|
|
2021
Q2 | $208K | Buy |
3,877
+314
| +9% | +$16.8K | ﹤0.01% | 2917 |
|
|
2021
Q1 | $189K | Buy |
3,563
+32
| +0.9% | +$1.7K | ﹤0.01% | 2842 |
|
|
2020
Q4 | $168K | Buy |
3,531
+388
| +12% | +$18.5K | ﹤0.01% | 2879 |
|
|
2020
Q3 | $190K | Sell |
3,143
-225
| -7% | -$13.6K | ﹤0.01% | 2706 |
|
|
2020
Q2 | $135K | Buy |
+3,368
| New | +$135K | ﹤0.01% | 2893 |
|
|
2019
Q2 | – | Sell |
-2,953
| Closed | -$79K | – | 2979 |
|
|
2019
Q1 | $79K | Sell |
2,953
-56
| -2% | -$1.5K | ﹤0.01% | 2887 |
|
|
2018
Q4 | $39K | Buy |
3,009
+944
| +46% | +$12.2K | ﹤0.01% | 2958 |
|
|
2018
Q3 | $50K | Sell |
2,065
-129
| -6% | -$3.12K | ﹤0.01% | 2908 |
|
|
2018
Q2 | $98K | Buy |
2,194
+197
| +10% | +$8.8K | ﹤0.01% | 2873 |
|
|
2018
Q1 | $136K | Sell |
1,997
-21
| -1% | -$1.43K | ﹤0.01% | 2688 |
|
|
2017
Q4 | $121K | Sell |
2,018
-631
| -24% | -$37.8K | ﹤0.01% | 2748 |
|
|
2017
Q3 | $176K | Buy |
2,649
+59
| +2% | +$3.92K | ﹤0.01% | 2784 |
|
|
2017
Q2 | $185K | Buy |
2,590
+72
| +3% | +$5.14K | ﹤0.01% | 2785 |
|
|
2017
Q1 | $140K | Buy |
2,518
+715
| +40% | +$39.8K | ﹤0.01% | 2732 |
|
|
2016
Q4 | $73K | Buy |
1,803
+201
| +13% | +$8.14K | ﹤0.01% | 2812 |
|
|
2016
Q3 | $71K | Buy |
1,602
+513
| +47% | +$22.7K | ﹤0.01% | 2841 |
|
|
2016
Q2 | $44K | Buy |
+1,089
| New | +$44K | ﹤0.01% | 2966 |
|
|
2014
Q2 | – | Sell |
-1,268
| Closed | -$38K | – | 3023 |
|
|
2014
Q1 | $38K | Sell |
1,268
-72
| -5% | -$2.16K | ﹤0.01% | 2967 |
|
|
2013
Q4 | $53K | Hold |
1,340
| – | – | ﹤0.01% | 2997 |
|
|
2013
Q3 | $141K | Sell |
1,340
-6
| -0.4% | -$631 | ﹤0.01% | 2883 |
|
|
2013
Q2 | $174K | Buy |
+1,346
| New | +$174K | ﹤0.01% | 3048 |
|